CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Open-market sale Director sold 5,000 shares at an average $3.51 ($17,525)
- 3/A Insider 3/A
- 4 Option exercise 10% owner acquired 1,100,000 shares (option exercise)
- 4 Other acquisition 10% owner acquired 1,100,000 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,000 shares at $2.50 ($2,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 32,332 shares at an average $2.39 ($77,305)
- 4 Open-market sale Vice President sold 36,000 shares at an average $2.88 ($103,528)
- 4 Open-market sale CFO sold 22,500 shares at an average $2.54 ($57,156)
- 4 Open-market sale Vice President & Secretary sold 45,000 shares at an average $2.44 ($109,699)
- 4 Open-market sale Vice President sold 45,000 shares at an average $2.66 ($119,790)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition 10% owner acquired 1,100,000 shares (other)
- 4 Other acquisition 10% owner acquired 13,144 shares (other)
- 4 Other acquisition 10% owner acquired 3,429 shares (other)
- 4 Other acquisition 10% owner acquired 7,000 shares (other)
Page 23 of 37 · 722 filings